1. 2161 The prognostic significance of radiologic and pathologic factors after neoadyuvant chemotherapy for T3 rectal cancer (RC): 3-years update GEMCAD 0801 trial. (September 2015) Authors: Machado, I.; Patel, U.; Brown, G.; Salud, A.; Gil, M.; Montagut, C.; Busto, M.; Safont, M.; Maurel, J.; Ayuso, J.; Aparicio, J.; Feliu, J.; Vera, R.; Alonso, V.; Gallego, J.; Martin, M.; Pericay, C.; Ballesteros, E.; Santos, J.; Fernandez-Martos, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 227 Predictive serum biomarkers in metastatic colorectal cancer patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (GEMCAD 09-01). (September 2015) Authors: Pineda Losada, E.; Salud, A.; Vila-Navarro, E.; Safont, M.J.; Garcia-Giron, C.; Aparicio, J.; Vera, R.; Escudero, M.P.; Casado, E.; Bosch, C.; Bohn, U.; Perez Carrion, R.M.; Carmona Bayonas, A.; Ayuso, J.R.; Ripolles, T.; Bouzas, R.; Gironella, M.; Garcia-Albeniz, X.; Feliu, J.; Maurel, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient. (13th June 2015) Authors: Feliu, J.; Del Pozo, J. L.; Azanza, J. R.; García‐Muñoz, R.; Zabalza, A.; Gorosquieta, A.; Pérez‐Equiza, E.; Olavarría, E. Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 40:Number 5(2015:Oct.) Page Start: 601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of two-dimensional (2D)- and three-dimensional (3D)-culture models as drug testing platforms in GIST: experience with axitinib in vitro. (February 2017) Authors: Martínez-Marín, V.; Redondo, A.; Heredia, V.; Guerra, L.; Miguel-Martín, M.; Crespo, R.; Hardisson, D.; Feliu, J.; Mendiola, M. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EFFECTS ON THE HUMAN IMMUNE SYSTEM AFTER OBINUTUZUMAB MONOTHERAPY TREATMENT. (June 2017) Authors: Garcia‐Munoz, R.; Aguinaga, L.; Feliu, J.; Anton‐Remirez, J.; Jorge del Val, L.; Dominguez‐Garrido, E.; Rabasa, P.; Panizo, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. RESULTS OF PHASE II STUDY OF COMBINED IMMUNOTHERAPY WITH RITUXIMAB PLUS LYMPHOKINE‐ACTIVATED KILLER CELLS AS MAINTENANCE IN FOLLICULAR LYMPHOMA PATIENTS. (12th June 2019) Authors: Martinez Calle, N.; Diaz De Cerio, A.; Pena, E.; Garcia Muñoz, R.; Panizo, A.; Feliu, J.; Giraldo, P.; Rodriguez, M.; Grande, C.; Olave, T.; Andrade‐Campos, M.; Bandres, E.; Nuñez, J.; Inoges, S.; Panizo, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗